LBA82 Influenza-like illness and SARS-Cov-2 in the multicenter, prospective, observational INVIDIa-2 study (INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: A transversal challenge): A FICOG study
Gespeichert in:
| Veröffentlicht in: | Annals of oncology 2020-09, Vol.31, p.S1209-S1209 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | S1209 |
|---|---|
| container_issue | |
| container_start_page | S1209 |
| container_title | Annals of oncology |
| container_volume | 31 |
| creator | Bersanelli, M. Giannarelli, D. Verzoni, E. Buti, S. De Giorgi, U. Clemente, A. Filetti, M. Di Napoli, M. Calvetti, L. Ermacora, P. Catino, A.M. Guaitoli, G. Bonomo, P. Mazzoni, F. Veccia, A. Grosso, F. Maruzzo, M. Rossi, E. Grossi, F. Procopio, G. |
| description | |
| doi_str_mv | 10.1016/j.annonc.2020.08.2323 |
| format | Article |
| fullrecord | <record><control><sourceid>elsevier_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7506488</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0923753420424056</els_id><sourcerecordid>S0923753420424056</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2563-760b6c884603151d91329be3ff4d8062def137ab7d8e38b8800811f7a0158bdb3</originalsourceid><addsrcrecordid>eNqFkc1u1DAUhSMEEkPhEZC8BKkJtvPnsAANU1oijVqJQreWY99MPE2cyE6Chsftk9QhFRIrVl7ce87ne04QvCU4IphkH46RMKY3MqKY4giziMY0fhZsSJoVIcMJeR5scEHjME_j5GXwyrkjxjgraLEJHvZftoyi0tTtBOa3CFt9D0i3rQHnkDAK3W6_34a7fg4p0gaNDaBuakctwYxgz9FgezeAHPUM56ivHNhZjLo3okXl9V15UQovdOOkTuhdef1EQXdCSm3Ac5WWf_bRxWS1OSwAK4YT-qXHBpVdN_kt2YC8H3ptRv-FRld67K37iLZotMK4GazzNNmItgVzgPfL5LLc3Vyt3NfBi1q0Dt48vWfBz8uvP3bfwv3NVbnb7kNJ08yHk-Eqk4wlGY5JSlRBYlpUENd1ohjOqIKaxLmocsUgZhVjGDNC6lxgkrJKVfFZ8Gn1HaaqA7UEZEXLB6s7YU-8F5r_OzG64Yd-5nmKs4Qxb5CuBtJn6izUf7UE86VpfuRr03xpmmPGl6a97vOqA3_drMFyJzUYCUpb3wxXvf6PwyMtXLg-</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>LBA82 Influenza-like illness and SARS-Cov-2 in the multicenter, prospective, observational INVIDIa-2 study (INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: A transversal challenge): A FICOG study</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Bersanelli, M. ; Giannarelli, D. ; Verzoni, E. ; Buti, S. ; De Giorgi, U. ; Clemente, A. ; Filetti, M. ; Di Napoli, M. ; Calvetti, L. ; Ermacora, P. ; Catino, A.M. ; Guaitoli, G. ; Bonomo, P. ; Mazzoni, F. ; Veccia, A. ; Grosso, F. ; Maruzzo, M. ; Rossi, E. ; Grossi, F. ; Procopio, G.</creator><creatorcontrib>Bersanelli, M. ; Giannarelli, D. ; Verzoni, E. ; Buti, S. ; De Giorgi, U. ; Clemente, A. ; Filetti, M. ; Di Napoli, M. ; Calvetti, L. ; Ermacora, P. ; Catino, A.M. ; Guaitoli, G. ; Bonomo, P. ; Mazzoni, F. ; Veccia, A. ; Grosso, F. ; Maruzzo, M. ; Rossi, E. ; Grossi, F. ; Procopio, G.</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1016/j.annonc.2020.08.2323</identifier><language>eng</language><publisher>Elsevier Ltd</publisher><ispartof>Annals of oncology, 2020-09, Vol.31, p.S1209-S1209</ispartof><rights>2020 European Society for Medical Oncology</rights><rights>Copyright © 2020 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. 2020 European Society for Medical Oncology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2563-760b6c884603151d91329be3ff4d8062def137ab7d8e38b8800811f7a0158bdb3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids></links><search><creatorcontrib>Bersanelli, M.</creatorcontrib><creatorcontrib>Giannarelli, D.</creatorcontrib><creatorcontrib>Verzoni, E.</creatorcontrib><creatorcontrib>Buti, S.</creatorcontrib><creatorcontrib>De Giorgi, U.</creatorcontrib><creatorcontrib>Clemente, A.</creatorcontrib><creatorcontrib>Filetti, M.</creatorcontrib><creatorcontrib>Di Napoli, M.</creatorcontrib><creatorcontrib>Calvetti, L.</creatorcontrib><creatorcontrib>Ermacora, P.</creatorcontrib><creatorcontrib>Catino, A.M.</creatorcontrib><creatorcontrib>Guaitoli, G.</creatorcontrib><creatorcontrib>Bonomo, P.</creatorcontrib><creatorcontrib>Mazzoni, F.</creatorcontrib><creatorcontrib>Veccia, A.</creatorcontrib><creatorcontrib>Grosso, F.</creatorcontrib><creatorcontrib>Maruzzo, M.</creatorcontrib><creatorcontrib>Rossi, E.</creatorcontrib><creatorcontrib>Grossi, F.</creatorcontrib><creatorcontrib>Procopio, G.</creatorcontrib><title>LBA82 Influenza-like illness and SARS-Cov-2 in the multicenter, prospective, observational INVIDIa-2 study (INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: A transversal challenge): A FICOG study</title><title>Annals of oncology</title><issn>0923-7534</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNqFkc1u1DAUhSMEEkPhEZC8BKkJtvPnsAANU1oijVqJQreWY99MPE2cyE6Chsftk9QhFRIrVl7ce87ne04QvCU4IphkH46RMKY3MqKY4giziMY0fhZsSJoVIcMJeR5scEHjME_j5GXwyrkjxjgraLEJHvZftoyi0tTtBOa3CFt9D0i3rQHnkDAK3W6_34a7fg4p0gaNDaBuakctwYxgz9FgezeAHPUM56ivHNhZjLo3okXl9V15UQovdOOkTuhdef1EQXdCSm3Ac5WWf_bRxWS1OSwAK4YT-qXHBpVdN_kt2YC8H3ptRv-FRld67K37iLZotMK4GazzNNmItgVzgPfL5LLc3Vyt3NfBi1q0Dt48vWfBz8uvP3bfwv3NVbnb7kNJ08yHk-Eqk4wlGY5JSlRBYlpUENd1ohjOqIKaxLmocsUgZhVjGDNC6lxgkrJKVfFZ8Gn1HaaqA7UEZEXLB6s7YU-8F5r_OzG64Yd-5nmKs4Qxb5CuBtJn6izUf7UE86VpfuRr03xpmmPGl6a97vOqA3_drMFyJzUYCUpb3wxXvf6PwyMtXLg-</recordid><startdate>202009</startdate><enddate>202009</enddate><creator>Bersanelli, M.</creator><creator>Giannarelli, D.</creator><creator>Verzoni, E.</creator><creator>Buti, S.</creator><creator>De Giorgi, U.</creator><creator>Clemente, A.</creator><creator>Filetti, M.</creator><creator>Di Napoli, M.</creator><creator>Calvetti, L.</creator><creator>Ermacora, P.</creator><creator>Catino, A.M.</creator><creator>Guaitoli, G.</creator><creator>Bonomo, P.</creator><creator>Mazzoni, F.</creator><creator>Veccia, A.</creator><creator>Grosso, F.</creator><creator>Maruzzo, M.</creator><creator>Rossi, E.</creator><creator>Grossi, F.</creator><creator>Procopio, G.</creator><general>Elsevier Ltd</general><general>European Society for Medical Oncology. Published by Elsevier Ltd</general><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>202009</creationdate><title>LBA82 Influenza-like illness and SARS-Cov-2 in the multicenter, prospective, observational INVIDIa-2 study (INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: A transversal challenge): A FICOG study</title><author>Bersanelli, M. ; Giannarelli, D. ; Verzoni, E. ; Buti, S. ; De Giorgi, U. ; Clemente, A. ; Filetti, M. ; Di Napoli, M. ; Calvetti, L. ; Ermacora, P. ; Catino, A.M. ; Guaitoli, G. ; Bonomo, P. ; Mazzoni, F. ; Veccia, A. ; Grosso, F. ; Maruzzo, M. ; Rossi, E. ; Grossi, F. ; Procopio, G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2563-760b6c884603151d91329be3ff4d8062def137ab7d8e38b8800811f7a0158bdb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bersanelli, M.</creatorcontrib><creatorcontrib>Giannarelli, D.</creatorcontrib><creatorcontrib>Verzoni, E.</creatorcontrib><creatorcontrib>Buti, S.</creatorcontrib><creatorcontrib>De Giorgi, U.</creatorcontrib><creatorcontrib>Clemente, A.</creatorcontrib><creatorcontrib>Filetti, M.</creatorcontrib><creatorcontrib>Di Napoli, M.</creatorcontrib><creatorcontrib>Calvetti, L.</creatorcontrib><creatorcontrib>Ermacora, P.</creatorcontrib><creatorcontrib>Catino, A.M.</creatorcontrib><creatorcontrib>Guaitoli, G.</creatorcontrib><creatorcontrib>Bonomo, P.</creatorcontrib><creatorcontrib>Mazzoni, F.</creatorcontrib><creatorcontrib>Veccia, A.</creatorcontrib><creatorcontrib>Grosso, F.</creatorcontrib><creatorcontrib>Maruzzo, M.</creatorcontrib><creatorcontrib>Rossi, E.</creatorcontrib><creatorcontrib>Grossi, F.</creatorcontrib><creatorcontrib>Procopio, G.</creatorcontrib><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bersanelli, M.</au><au>Giannarelli, D.</au><au>Verzoni, E.</au><au>Buti, S.</au><au>De Giorgi, U.</au><au>Clemente, A.</au><au>Filetti, M.</au><au>Di Napoli, M.</au><au>Calvetti, L.</au><au>Ermacora, P.</au><au>Catino, A.M.</au><au>Guaitoli, G.</au><au>Bonomo, P.</au><au>Mazzoni, F.</au><au>Veccia, A.</au><au>Grosso, F.</au><au>Maruzzo, M.</au><au>Rossi, E.</au><au>Grossi, F.</au><au>Procopio, G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>LBA82 Influenza-like illness and SARS-Cov-2 in the multicenter, prospective, observational INVIDIa-2 study (INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: A transversal challenge): A FICOG study</atitle><jtitle>Annals of oncology</jtitle><date>2020-09</date><risdate>2020</risdate><volume>31</volume><spage>S1209</spage><epage>S1209</epage><pages>S1209-S1209</pages><issn>0923-7534</issn><eissn>1569-8041</eissn><pub>Elsevier Ltd</pub><doi>10.1016/j.annonc.2020.08.2323</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0923-7534 |
| ispartof | Annals of oncology, 2020-09, Vol.31, p.S1209-S1209 |
| issn | 0923-7534 1569-8041 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7506488 |
| source | EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| title | LBA82 Influenza-like illness and SARS-Cov-2 in the multicenter, prospective, observational INVIDIa-2 study (INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: A transversal challenge): A FICOG study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T19%3A40%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=LBA82%20Influenza-like%20illness%20and%20SARS-Cov-2%20in%20the%20multicenter,%20prospective,%20observational%20INVIDIa-2%20study%20(INfluenza%20Vaccine%20Indication%20During%20therapy%20with%20Immune%20checkpoint%20inhibitors:%20A%20transversal%20challenge):%20A%20FICOG%20study&rft.jtitle=Annals%20of%20oncology&rft.au=Bersanelli,%20M.&rft.date=2020-09&rft.volume=31&rft.spage=S1209&rft.epage=S1209&rft.pages=S1209-S1209&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1016/j.annonc.2020.08.2323&rft_dat=%3Celsevier_pubme%3ES0923753420424056%3C/elsevier_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_els_id=S0923753420424056&rfr_iscdi=true |